Michela Rosini

Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease.

Maurizio Recanatini, Maria Laura Bolognesi, Andrea Cavalli, 2007, Journal of medicinal chemistry.

Combining galantamine and memantine in multitargeted, new chemical entities potentially useful in Alzheimer's disease.

Luca Goldoni, Giovanni Bottegoni, Andrea Cavalli, 2012, Journal of medicinal chemistry.

Multi-target-directed ligands to combat neurodegenerative diseases.

Maurizio Recanatini, Maria Laura Bolognesi, Andrea Cavalli, 2008, Journal of medicinal chemistry.

Multitargeted drugs discovery: balancing anti-amyloid and anticholinesterase capacity in a single chemical entity.

Maria Laura Bolognesi, Vincenza Andrisano, Fabiana Morroni, 2011, Bioorganic & medicinal chemistry letters.

Inhibition of acetylcholinesterase, beta-amyloid aggregation, and NMDA receptors in Alzheimer's disease: a promising direction for the multi-target-directed ligands gold rush.

David W McClymont, Andrea Cavalli, David W. McClymont, 2008, Journal of medicinal chemistry.

Polypharmacology: the rise of multitarget drugs over combination therapies.

M. Rosini, Michela Rosini, 2014, Future medicinal chemistry.

Progress in acetylcholinesterase inhibitors for Alzheimer's disease: an update

Maria Laura Bolognesi, Anna Minarini, Vincenzo Tumiatti, 2008 .

Rational approach to discover multipotent anti-Alzheimer drugs.

Vincenza Andrisano, Anna Minarini, Carlo Melchiorre, 2005, Journal of medicinal chemistry.

Novel class of quinone-bearing polyamines as multi-target-directed ligands to combat Alzheimer's disease.

Maurizio Recanatini, Maria Laura Bolognesi, Andrea Cavalli, 2007, Journal of medicinal chemistry.